Axsome Therapeutics AXSM
NASDAQ AXSM
$147.96 +6.99 (+4.95%)
As of: Nov 11, 2026 · 3:12 PM EST

Axsome Therapeutics (AXSM) Invested Capital (2014 - 2026)

Updated

Axsome Therapeutics' Invested Capital was $293.5 million in Q3 2026, up 12.3% from $261.37 million a year earlier and up 8.2% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Invested Capital (2014 - 2026) Analysis & Trends

For FY2025, Invested Capital at Axsome Therapeutics came in at $276.04 million, up 16.1% from FY2024.

  • Invested Capital shows a five-year compound annual growth rate of 11.2% (FY2020 to FY2025).
  • In earlier years, Invested Capital was $237.73 million in FY2024 (-35.6%), $369.05 million in FY2023 (+81.1%), $203.82 million in FY2022 (+214.9%) and $64.72 million in FY2021 (-60.1%).
  • The Q3 2026 figure marks the highest quarterly Invested Capital since Q1 2024.
  • Compared with a year earlier, Invested Capital has increased for four straight quarters, with an average decline of 4.9% over the last eight quarters.
  • The best year-over-year quarter for Invested Capital over five years was Q2 2023 (growth of 319.3%); the worst was Q4 2021 (a decline of 60.1%).
  • Per Business Quant data, AXSM's Invested Capital in the three quarters before Q3 2026 was $271.26 million (Q2 2026), $242.44 million (Q1 2026) and $276.04 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Axsome Therapeutics 7.41 Bn 6.15 Bn 241.89 Mn 293.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 293.50 Mn
Jun 30, 2026 271.26 Mn
Mar 31, 2026 242.44 Mn
Dec 31, 2025 276.04 Mn
Sep 30, 2025 261.37 Mn
Jun 30, 2025 260.62 Mn
Mar 31, 2025 234.58 Mn
Dec 31, 2024 237.73 Mn
Sep 30, 2024 272.90 Mn
Jun 30, 2024 282.18 Mn
Mar 31, 2024 322.73 Mn
Dec 31, 2023 369.05 Mn
Sep 30, 2023 446.95 Mn
Jun 30, 2023 455.62 Mn
Mar 31, 2023 259.43 Mn
Dec 31, 2022 203.82 Mn
Sep 30, 2022 251.27 Mn
Jun 30, 2022 108.66 Mn
Mar 31, 2022 64.01 Mn
Dec 31, 2021 64.72 Mn
API Access

Axsome Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=AXSM&period=max&api_key=YOUR_API_KEY